Aid agencies must invest more in strengthening health systems and infrastructure to avoid the catastrophic consequences of multidrug-resistant tuberculosis, U.K. parliamentarians have warned. But prevention is not only dependent on drug development, senior figures in the pharmaceutical sector have told Devex.
Sign in or join Devex to read the rest
Not only will you get to finish this article, you will also unlock access to community content from our global team of journalists covering the latest global health, humanitarian aid and international development news. And it's totally free.